Navigation Links
Wayne State proves targeted tumor freezing therapy increases ovarian cancer survival
Date:2/16/2012

DETROIT Ovarian cancer, which killed 15,000 American women last year, is one of the deadliest forms of cancer. A team of Wayne State University School of Medicine researchers recently proved that freezing tumors increases survival rates in ovarian cancer patients.

The "freeze and destroy" technique is an alternative for local treatment of cancerous tumors, said Peter Littrup, M.D., professor of radiology in the School of Medicine and director of imaging core and radiological research at the Barbara Ann Karmanos Cancer Institute.

Ovarian cancer is the most damaging cancer to attack the female reproductive system, with close to 22,000 women diagnosed each year, according to the National Institutes of Health. While surgery and chemotherapy have proved effective in treating cancer as a systemic disease, cryoablation is an option when the disease is in the late stages and is oligometastatic, meaning the tumors are limited in number and location.

Hyun Bang, M.D., a resident in WSU's Department of Radiology, presented the findings at the International Symposium on Endovascular Therapy in Miami, Fla., last month. In 98 percent of the 21 patients surveyed in the study, a survival rate of 56 months, or approximately 4.6 years, was reported. The majority of women whose tumors aren't successfully removed surgically some 60 percent according to studies survive only seven months to 2.5 years in comparison.

The study also concluded that medical costs were on average $26,806 per life year saved, nearly 75 percent less than the current standard of $100,000. (Average cost is $15,000 per treatment.) Littrup credited Bang with recognizing the evidence of effective data and taking the initiative to prove his technique worked.

"We hit a home run," Bang said.

The WSU team treated 48 tumors on the soft tissue, liver and lungs of 21 women over seven years in an outpatient setting. The treatment is performed using an extremely cold needle inserted into the skin, using imaging technology such as ultrasound for guidance. The treatment, called cryoablation, causes less pain and faster recovery than surgery.

In the study, "Cryoablation of Metastatic Ovarian Cancer for Local Tumor Control: Improved Survival and Estimated Cost-Effectiveness," Littrup and Bang, along with a team of researchers, demonstrate that targeted therapy for tumors in ovarian cancer patients increases survival and lessens recurrence rates in patients in the very late stages of the disease.

Armed with at least seven years of data, Bang recognized the long-term effectiveness of the treatment and the financial benefits, leaning on his pre-doctoral experience in economics and finance. If you have enough evidence and proven data, "eventually, people will start listening," Bang said.

The team has published two papers related to the findings as they relate to kidney and lung cancers, with a third recently submitted on colon cancer.

Littrup has cryoablated approximately 1,000 tumors to date in various soft tissues and organs, starting with the prostate in 1992.


'/>"/>

Contact: Julie O'Connor
julie.oconnor@wayne.edu
313-577-8845
Wayne State University - Office of the Vice President for Research
Source:Eurekalert

Related medicine news :

1. Community Health Systems, Inc.s Wayne T. Smith and Larry Cash Named Americas Top Healthcare CEO and CFO
2. Wayne State University study predicts risk of memory loss in healthy, older adults
3. Speaking the same language means better health care quality, Wayne State University study finds
4. Wayne State University researchers publish results settling multiple sclerosis debate
5. Wayne State study links testosterone with mens ability to woo potential mates
6. Wayne State leads study to improve management of cancer pain in African Americans
7. Wayne State researchers find new way to examine major depressive disorder in children
8. Wayne State University researchers win grant from the NSF to target tinnitus
9. Religion benefits traumatic brain injury victims, Wayne State University research finds
10. Health providers should emphasize breast cancer screening, Wayne State University research finds
11. Wayne State University researcher argues that sex reduces genetic variation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Linda, Ca (PRWEB) , ... January 19, 2017 ... ... virtual events for tech innovators, engineers, and scientists from around the world, announces ... site offers users a quick and easy portal to research breakthroughs and trending ...
(Date:1/19/2017)... Utah (PRWEB) , ... January 19, 2017 , ... ... Festival in a medical capacity this year. Drs. Alexander Paziotopoulos, Andrew Petersen and ... provide a condensed version of the clinic’s leading recovery program. , “We ...
(Date:1/19/2017)... ... 2017 , ... Bio-Optronics Inc. is proud to announce the ... to seamlessly integrate and streamline the way researchers prepare and conduct patient visits. ... and improving efficiency significantly for users – a first in the CTMS industry. ...
(Date:1/19/2017)... ... 19, 2017 , ... Workrite Ergonomics announced this week the ... privacy panel system was designed to deliver the ideal blend of acoustic and ... provide the visual privacy required to maintain concentration levels and increase productivity. The ...
(Date:1/19/2017)... ... January 19, 2017 , ... Rountree Brady Insurance Agency, ... communities throughout eastern Georgia, is embarking on a charity effort to raise awareness ... more Americans every year than anything else, yet risk factors associated with heart ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Jan. 19, 2017 The Global Therapy Partnering ... access to partnering deals and agreements entered into by ... partnering deals - Top deals by value - Deals ... technology type The report provides understanding and access ... the world,s leading healthcare companies. The report provides ...
(Date:1/19/2017)... 2017 Report Details ... Alzheimer,s Disease Therapeutics ... – our new study reveals trends, R&D progress, and ... affecting the Alzheimer,s disease therapeutics and diagnostics market. Our ... questions: - How is the Alzheimer,s disease therapeutics and ...
(Date:1/19/2017)... , Jan. 19, 2017  Stealth BioTherapeutics Inc. ( ... treat mitochondrial dysfunction, today announced new additions to its ... as Chief Medical Officer, and Daniel Geffken ... that Jim Carr , Pharm.D. has been promoted ... are pleased to welcome Doug and Daniel to our ...
Breaking Medicine Technology: